Acute pharmacological degradation of ERK5 does not inhibit cellular immune response or proliferation-Reference-Cited by-同舟云学术

Acute pharmacological degradation of ERK5 does not inhibit cellular immune response or proliferation

Published:2022-11 Issue:11 Volume:29 Page:1630-1638.e7
ISSN:2451-9456
Container-title:Cell Chemical Biology
language:en
Short-container-title:Cell Chemical Biology

Author:

You Inchul,Donovan Katherine A.,Krupnick Noah M.,Boghossian Andrew S.,Rees Matthew G.,Ronan Melissa M.,Roth Jennifer A.,Fischer Eric S.,Wang Eric S.,Gray Nathanael S.^ORCID

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,Biochemistry

Reference37 articles.

1. Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase;Abe;J. Biol. Chem.,1996

2. 3' UTR seed matches, but not overall identity, are associated with RNAi off-targets;Birmingham;Nat. Methods,2006

3. Multifunctional role of Erk5 in multiple myeloma;Carvajal-Vergara;Blood,2005

4. Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome;Donovan;Elife,2018

5. Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2;Esparís-Ogando;Mol. Cell Biol.,2002

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The ERK5 pathway in BRAFV600E melanoma cells plays a role in development of acquired resistance to dabrafenib but not vemurafenib;FEBS Letters;2024-07-08

2. The impact of E3 ligase choice on PROTAC effectiveness in protein kinase degradation;Drug Discovery Today;2024-07

3. Design, Synthesis, and Biological Evaluation of Proteolysis-Targeting Chimeras as Highly Selective and Efficient Degraders of Extracellular Signal-Regulated Kinase 5;Journal of Medicinal Chemistry;2023-09-26

4. The significance of ERK5 catalytic-independent functions in disease pathways;Frontiers in Cell and Developmental Biology;2023-08-04

5. Etiopathogenic role of ERK5 signaling in sarcoma: prognostic and therapeutic implications;Experimental & Molecular Medicine;2023-06-19